LIPELLA PHARMACEUTICALS INC (LIPO) Stock News
NASDAQ:LIPO - Nasdaq - US53630L2097 - Common Stock - Currency: USD
LIPO Latest News, Press Releases and Analysis
Which stocks are moving on Thursday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Thursday's session: most active stocks
Thursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Thursday's session: top gainers and losers
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Thursday's session: gap up and gap down stocks
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
Which stocks are moving before the opening bell on Thursday?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus ...
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus...
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group...
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform...
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split...
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference...
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform...
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
PITTSBURGH, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology...
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research...
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference...
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q2 2024
Lipella Pharmaceuticals just reported results for the second quarter of 2024.
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lipella Pharmaceuticals (NASDAQ:LIPO) just reported results for the second quar...
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?
LuxUrban Hotels stock is down on Monday after the company priced a public offering of LUXH shares below its prior closing price.
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold.
Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?
Lipella Pharmaceuticals stock is up on Monday after the company notified LIPO investors of a Phase 2a clinical trial of LP-310 starting.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients...
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus...
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lipella Pharmaceuticals (NASDAQ:LIPO) just reported results for the first quart...